Holdings of BIOS Capital Management, LP
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 6 in 1 countries
- Top ten
- 100.0 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Actuate Therapeutics, Inc. | 10,049,996 | 27.5M $ | |
| 2 | Opus Genetics Inc | 3,683,429 | 16.8M $ | |
| 3 | Cognition Therapeutics Inc | 6,000,000 | 4.6M $ | |
| 4 | REIN THERAPEUTICS INC | 1,982,375 | 2.6M $ | |
| 5 | Lantern Pharma Inc | 864,435 | 1.2M $ | |
| 6 | IN8BIO INC | 167,805 | 248.4K $ |
Sector breakdown
- Unattributed 100.0 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 100.0 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 6 | 52.9M $ | 100.00 % |
Cite this page
Titelia. "Holdings of BIOS Capital Management, LP". https://titelia.com/en/funds/US13F1813845